OnKure Therapeutics, Inc. (OKUR) — Financial statements
Income statement, balance sheet, and cash flow for OnKure Therapeutics, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.83 | 0.00 | 0.00 | 0.00↓100.0% | 0.05 | |
| Gross Profit | -0.83 | 0.00 | 0.00 | 0.00↑100.0% | -0.05 | |
| Operating Expenses | ||||||
| R&D Expenses | 48↑10.2% | 44↑36.4% | 32↑24.2% | 26↓8.0% | 28 | |
| General & Administrative Expenses | 15↑38.7% | 11↑119.8% | 5↑23.4% | 4 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 15↑38.7% | 11↑119.8% | 5↑23.4% | 4↓66.5% | 12 | |
| Other Expenses | -0.83 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 62↑14.2% | 54↑47.3% | 37↑24.1% | 30↓25.2% | 40 | |
| Total Costs & Expenses | 63↑15.7% | 54↑47.3% | 37↑24.1% | 30↓25.2% | 40 | |
| Operating Results | ||||||
| Operating Income | -63↓15.7% | -54↓47.3% | -37↓24.1% | -30↑25.2% | -40 | |
| Depreciation & Amortization | 0.83↑25.4% | 0.66↑18.2% | 0.56↑44.7% | 0.39↑674.0% | 0.05 | |
| EBITDA | -62↓20.1% | -52↓48.8% | -35↓18.3% | -29↑26.0% | -40 | |
| EBIT | -63↓20.2% | -52↓48.3% | -35↓18.6% | -30↑25.2% | -40 | |
| Interest & Other Income | ||||||
| Net Interest Income | 3↑100.9% | 2↑5.5% | 2↑539.0% | 0.25 | 0.00 | |
| Interest Income | 3↑70.9% | 2↑24.0% | 2↑539.0% | 0.25 | 0.00 | |
| Interest Expense | 0.00↓100.0% | 0.30 | 0.00 | 0.00 | 0.00 | |
| Non-Operating Income | 0.00↑100.0% | -2↓24.0% | -2 | 0.00↑100.0% | -0.05 | |
| Other Income / Expenses | 3↑100.4% | 2↑5.5% | 2↑539.0% | 0.25↑429.2% | 0.05 | |
| Income Before Tax | -60↓13.0% | -53↓49.2% | -35↓19.6% | -30↑25.8% | -40 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -60↓13.0% | -53↓49.2% | -35↓19.6% | -30↑25.8% | -40 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -60↓13.0% | -53↓49.2% | -35↓19.6% | -30↑25.8% | -40 | |
| Bottom-Line Net Income | -60↓13.0% | -53↓49.2% | -35↓19.6% | -30↑25.8% | -40 | |
| EPS (Basic) | -4.40↓11.4% | -3.95↓49.1% | -2.65↓19.9% | -2.21↑89.9% | -21.92 | |
| EPS (Diluted) | -4.40↓11.4% | -3.95↓49.1% | -2.65↓19.9% | -2.21↑89.9% | -21.92 | |
| Weighted Average Shares | 14↑1.3% | 13↑0.0% | 13↑0.0% | 13↑635.2% | 2 | |
| Weighted Average Diluted Shares | 14↑1.3% | 13↑0.0% | 13↑0.0% | 13↑635.2% | 2 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.